About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Jubilant Life Sciences gets FDA Nod for Anti-Depressant Drug

by Kathy Jones on October 20, 2013 at 7:55 PM
Font : A-A+

 Jubilant Life Sciences gets FDA Nod for Anti-Depressant Drug

Jubilant Life Sciences has announced that it has received approval from the US Food and Drug Administration (FDA) for its anti-depressant drug Bupropion Hydrochloride.

"We have also received approval for the same extended drug used as smoking cessation aid. Both formulations are generic version of GlaxoSmithKline's Wellbutrin and Zyban tablets respectively," the company said in a statement here.

Advertisement

The market size for the twin products is estimated to be around $518 million annually.

"We propose to launch both the drugs in this quarter of 2013-14," the statement said.

The company has filed 649 applications for formulations till June, of which 189 were approved in different geographies the world over, including 58 abbreviated new drug application (ANDA) in the US and 41 dossier filings in Europe.
Advertisement

With 10 production facilities across India, Canada and the US, Jubilant manufactures and supplies active pharmaceutical ingredients (APIs), generics, specialty pharmaceuticals and life science ingredients, besides providing services in contract manufacturing and drug discovery and development.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
World Osteoporosis Day 2021 -
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Hypermobility Syndrome 

Recommended Reading
Depression
Depression is one of the most common mental disorders affecting approximately 340 million people in ...
Depression Symptom Evaluation
Depression occurs due to alterations in the levels of neurotransmitters in the brain. ...
Holistic Management for Depression
Depression is a common disorder and many worldwide suffer from depression. Early recognition of ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Hypermobility Syndrome
Hypermobility Syndrome is a condition in which a person can move his joints far beyond the normal .....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use